[Homocysteine, methylenetetrahydrofolate reductase/C677T genotype and risk for coronary heart disease. The AtheroGene study].
Blankenberg
S
S
II. Medizinische Klinik und Poliklinik, Johannes Gutenberg-Universität Mainz, Germany. stefan.blankenberg@uni-mainz.de
Rupprecht
H J
HJ
Peetz
D
D
Bickel
C
C
Hofman
K P
KP
Tiret
L
L
Meyer
J
J
D016022:Case-Control Studies; D003327:Coronary Disease / Q000097:blood / Q000453:epidemiology / Q000209:etiology*; D005260:Female; D005492:Folic Acid / Q000097:blood; D005838:Genotype; D005858:Germany / Q000453:epidemiology; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D016015:Logistic Models; D008297:Male; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D008875:Middle Aged; D000587:Oxidoreductases Acting on CH-NH Group Donors / Q000235:genetics*; D011110:Polymorphism, Genetic; D015995:Prevalence; D012307:Risk Factors; D014805:Vitamin B 12 / Q000097:blood
D006710:Homocysteine; D005492:Folic Acid; D000587:Oxidoreductases Acting on CH-NH Group Donors; D042965:Methylenetetrahydrofolate Reductase (NADPH2); D014805:Vitamin B 12
Homozystein, Methylentetrahydrofolatreduktase/C677T-Genotyp und Risiko für koronare Herzkrankheit. Die AtheroGene Studie.